Log In
Print this Print this

GBT-201, RGN-259

  Manage Alerts
Collapse Summary General Information
Company RegeneRx Biopharmaceuticals Inc.
DescriptionTopical eye drop formulation of thymosin beta 4 (TB4), a naturally occurring 43-amino acid peptide
Molecular Target Thymosin beta 4 (TB4)
Mechanism of Action 
Therapeutic ModalityPeptide

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments





 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today